Aspen aiming for 1.3bn dose per year Covid-19 vaccine capacity by 2024

Up from 250m doses.
Image: Supplied

South Africa’s Aspen Pharmacare is aiming to ramp up its Covid-19 vaccine manufacturing capacity to 1.3 billion doses a year by February 2024, up from annual output of around 250 million doses now, the company’s CEO told Reuters.

Aspen is doing the final stages of manufacturing for Johnson & Johnson’s Covid-19 vaccine in a so-called “fill and finish” deal, but CEO Stephen Saad said in an interview that the companies were close to announcing a broader deal for Aspen to produce Johnson & Johnson’s Covid-19 shot under licence.

VIDEOS

COMMENTS   3

Sort by:
  • Oldest first
  • Newest first
  • Top voted

You must be signed in and an Insider Gold subscriber to comment.

SUBSCRIBE NOW SIGN IN

Dear Aspen — Where exactly are your paying customers gonna come from ???
Africa does not pay !!!

As far as I understand the agreement with JJ , JJ is the customer so not Aspens problem as far as payments

“South Africa’s Aspen Pharmacare is aiming to ramp up its Covid-19 vaccine manufacturing capacity to 1.3 billion doses a year by February 2024”. Do you people all get it now? This is never meant to end, it is meant to be profitable ad infinitum.

End of comments.

LATEST CURRENCIES  

USD / ZAR
GBP / ZAR
EUR / ZAR
BTC / USD

Podcasts

INSIDER SUBSCRIPTION APP VIDEOS RADIO / LISTEN LIVE SHOP OFFERS WEBINARS NEWSLETTERS TRENDING

Follow us:

Search Articles:
Click a Company: